Amgen Recalls Prolia Injection Due to Visible Cellulose Fibers
Amgen is recalling 4,163 Prolia (denosumab) prefilled syringes because visible cellulose fibers were found during routine quality checks.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class II, which corresponds to a 'Severe' severity score under the rubric, as it may cause temporary or medically reversible adverse health consequences.
Plain-English summary
Amgen, Inc. is recalling 4,163 prefilled syringes of Prolia (denosumab) Injection, 60 mg/mL. The recall affects Lot #1037592, which has an expiration date of 07/15. The product is distributed nationwide, in Puerto Rico, Canada, Mexico, and through clinical distribution in Europe.
The recall was initiated because visible cellulose fibers were observed in a small number of prefilled syringes during a routine quality examination. The FDA has classified this recall as Class II, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Healthcare providers and patients should stop using the affected syringes and contact Amgen or their local FDA office for further instructions. Consumers should check their medication packaging for the specific lot number and expiration date listed above to determine if they are affected.
The recalled product
- Product
- PROLIA (DENOSUMAB)
- Brand
- PROLIA
- Manufacturer
- Amgen, Inc.
- Category
- Drug — Prescription Injection
- Affected units
- 4,163
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 1037592
- Exp 07/15
UPCs (1)
- 355513710015
Distribution
Related recalls
Same brand · PROLIA
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
Same manufacturer · Amgen, Inc.
See all →- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- CriticalAmerican Regent Recalls Papaverine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Nitroglycerin Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Cyanocobalamin Injections Due to Particulate Matter
FDA (Drugs) · 2026-08-26